StephenR.U.WalshMD
Infectious Disease • Boston, MAInstructor in Medicine, Beth Israel Deaconess Medical Center
Are you Dr. Walsh?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 23 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
55 Fruit St
Boston, MA 02114Phone+1 617-726-3812Fax+1 617-726-7416- Is this information wrong?
Summary
- Dr. Stephen Walsh, MD is an infectious disease specialist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Brigham and Women's Hospital and is an Instructor in Medicine at Beth Israel Deaconess Medical Center.
Education & Training
Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2001 - 2006
McGill University Faculty of MedicineClass of 1998
Certifications & Licensure
MA State Medical License 2000 - 2025- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Evaluating the Safety and Pharmacokinetics of VRC07-523LS in the Sera and Mucosae of Healthy, HIV-Uninfected Adult Participants Start of enrollment: 2019 Jan 18
- Evaluating the Safety and Immunogenicity of Polyvalent DNA/gp120 HIV Vaccine in Healthy, HIV-uninfected Adults Start of enrollment: 2021 Jul 08
Roles: Principal Investigator
Publications & Presentations
PubMed
- A HIV-1 Gp41 Peptide-Liposome Vaccine Elicits Neutralizing Epitope-Targeted Antibody Responses in Healthy Individuals.Nathan B Erdmann, Wilton B Williams, Stephen R Walsh, Nicole Grunenberg, Paul T Edlefsen, Paul A Goepfert, Derek W Cain, Kristen W Cohen, Janine Maenza, Kenneth H Maye...> ;Medrxiv. 2024 Mar 18
- Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.Axfors, C., Schmitt, A., Janiaud, P., Van't Hooft, J., Abd-Elsalam, S., Abdo, E., Abella, B., Akram, J., Amaravadi, R., Angus, D., Arabi, Y., Azhar, S., Baden, L., Bak...> ;Nature Communications. 2024 Feb 5
- 1 citationsImmunogenicity of quadrivalent meningococcal conjugate vaccine in frequent platelet donors.Michaël Desjardins, Phoebe Cunningham, Xhoi Mitre, Djenane Pierre, Christina Montesano, Tenaizus Woods, Karina Oganezova, Jonathan H Krauss, Salena S Von, John A Kupel...> ;Blood. 2023 Jul 13
- Join now to see all
Press Mentions
Trial Is Now Testing the Promise of mRNA Technology to Make Better Flu VaccinesJanuary 3rd, 2023- Distribution of COVID Vaccine Will Present ChallengesNovember 14th, 2020
- When Can We Expect A Coronavirus Vaccine?July 29th, 2020
Grant Support
- Dermatotropic Cellular Immune Responses Induced By A Novel Smallpox VaccineNational Institute Of Allergy And Infectious Diseases2010–2012
- Identification Of Orthopoxvirus-Derived CD8+ T Cell Epitopes MacaquesNational Center For Research Resources2006–2010
- Analysis Of Immunoregulatory Vaccinia GenesNational Center For Research Resources2006–2007
Hospital Affiliations
Brigham and Women's HospitalBoston, Massachusetts
